Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data.
about
Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney diseaseAtrial fibrillation in acute ST-elevation myocardial infarction: clinical and prognostic featuresEffect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trialsTemporal trends and outcomes associated with atrial fibrillation observed during acute coronary syndrome: Real-world data from the Acute Coronary Syndrome Israeli Survey (ACSIS), 2000-2013.Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiographyMortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysisAtrial fibrillation and death after myocardial infarction: a community study.Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study.Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance.Prognostic significance of incident atrial fibrillation following STEMI depends on the timing of atrial fibrillation.The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg.Is atrial fibrillation an inflammatory disorder?Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence.Trends in atrial fibrillation in patients hospitalized with an acute coronary syndromeStatins therapy can reduce the risk of atrial fibrillation in patients with acute coronary syndrome: a meta-analysis.The renin-angiotensin system: a therapeutic target in atrial fibrillation.Dynamic TIMI risk score for STEMI.Predictors of Elevated Cardiac Enzyme Levels in Hospitalized Patients with Atrial Fibrillation and No Known Coronary Artery Disease.Post PCI atrial fibrillation.The role of the renin-angiotensin system blocking in the management of atrial fibrillation.Acetylcholine-regulated K+ current remodelling in the atrium after myocardial infarction and valsartan administrationAtrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.The Role Of Renin Angiotensin System In Atrial Fibrillation.Atrial Fibrillation in Acute Coronary SyndromeCo-existence of Atrial Fibrillation with Myocardial Infarction - Unhealthy Combination.Omega-3 Polyunsaturated Fatty Acid Supplementation: Mechanism and Current Evidence in Atrial Fibrillation.Mortality Risk Associated with AF in Myocardial Infarction Patients.Atrial Fibrillation Complicating Acute Coronary Syndromes.Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation.New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.New-onset atrial fibrillation and acute coronary syndrome.Upstream effect for atrial fibrillation: still a dilemma?Can we predict outcomes in atrial fibrillation?Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis.Management of atrial fibrillation in patients undergoing percutaneous coronary intervention.
P2860
Q26801625-D1DF5F61-9BDA-400C-9D2E-FB3183960DF9Q26858944-B37735C1-5652-42A3-ABBD-EF0D4A5D6085Q28087109-F2E98B23-B942-4E7D-9B86-4AB5502B315DQ31146916-653F7A5F-0498-4979-9F9B-1B6EAD79E081Q33798432-EE6C2A3A-C363-47CF-A2CF-6D28E01C8297Q33811339-5A391D5E-A8E5-4800-A89B-C6529B8CF9E4Q33899134-61CCE04D-F0F4-4287-B536-0D8A953D1094Q34034720-19AD6A79-4108-473F-86E7-EE12ACDB6177Q34863616-EE8E4900-91A8-4B55-8DD1-38CC16AA0239Q35125950-9817011A-FB46-4B35-A238-45B098C93BC3Q35612755-6E44F0C6-F413-402B-875E-2D176A23CB35Q35828176-B26C1A9B-0B5A-4D67-9ED8-FBADD3EAAC53Q35991820-E8D2CC40-B554-42AA-B4F2-D53065DC11B4Q36077771-262BCCDB-D73E-4BB9-BC4A-04D3305EF9C3Q36309624-468F8317-C6B7-4436-BA2B-B46A05349B4CQ36324110-0AA5442A-773E-41A6-B309-1A215D05137DQ36473161-B4443AB5-4456-4882-A6EA-45E5E26477D0Q36540145-FA6E7063-4991-49B4-A70D-5FF6C018B58EQ36596749-8E8418D2-54A7-4EEE-9F3A-8E2665FB2CFBQ36701761-AEE1BB45-7589-426F-AD0F-5F7A216B9598Q36736475-9927885C-2EF9-4E7F-BDE9-FBE75E505A41Q36851061-184572E1-94BF-48B8-8EA2-4912708788BEQ37166906-0B9BDC96-B77C-475B-AF4E-A5D3876AB2B0Q37252887-554632ED-ED77-4C1C-A111-9958F3B6F145Q37358467-302571ED-3A50-4B51-80F4-BEEF341B0972Q37359616-64DF2542-0864-4289-AD76-3D9786254219Q37394525-5F52E6EF-AB0B-4758-B6D5-A861A14C26CEQ37469038-8075EB12-6D5C-44F4-BCBB-8C3F73E9B6CFQ37495872-AE700A8B-8361-45D4-B316-D9FE5B563086Q37496113-4EB5C62E-E8E9-41DB-9F04-4607E50F0A66Q37496128-6ED93718-8F2F-44CD-8B5E-74EC6E228325Q37496236-BB7FD987-EC81-46F5-A69E-FB762FC80E06Q37496257-4DE88B86-DCC9-4628-BD99-DB65AD19523BQ37506170-71D32463-31FA-49D4-8B05-D44DA303136CQ37648444-3C2A5158-C582-450A-81A4-2BB14B6983B1Q37770107-70AA39DD-FC79-4CCF-AD14-BFE92C2A6E84Q37804417-9C3530B3-89DB-44B4-8774-4057CEDDC43AQ37975984-0B10DFC1-BDA5-42BB-9CFC-0B677673CB06Q38028359-F7DC963A-A319-4048-B4AF-7FDCF8D27BCDQ38210217-E7CCAB14-6BA2-4C76-911A-2DE55C9D87DD
P2860
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Incidence and prognostic signi ...... infarction: the GISSI-3 data.
@ast
Incidence and prognostic signi ...... infarction: the GISSI-3 data.
@en
type
label
Incidence and prognostic signi ...... infarction: the GISSI-3 data.
@ast
Incidence and prognostic signi ...... infarction: the GISSI-3 data.
@en
prefLabel
Incidence and prognostic signi ...... infarction: the GISSI-3 data.
@ast
Incidence and prognostic signi ...... infarction: the GISSI-3 data.
@en
P2093
P2860
P356
P1433
P1476
Incidence and prognostic signi ...... infarction: the GISSI-3 data.
@en
P2093
A P Maggioni
F M Turazza
F Pizzetti
GISSI-3 Investigators
M G Franzosi
P2860
P304
P356
10.1136/HEART.86.5.527
P407
P577
2001-11-01T00:00:00Z